GLOW vs KLOW: peptide blend composition compared

Compare the documented GLOW and KLOW ingredients and labelled amounts: three components totalling 70 mg versus four totalling 80 mg.

Substantially revised on 3 October 2026 to focus on molecular identity, naming, chemistry, testing and documentation.

In the supplied declarations, KLOW adds 10 mg KPV to the same 10 mg BPC-157, 10 mg TB-500 and 50 mg GHK-Cu amounts listed for GLOW. The difference is one additional component, not an increase in every component.

GLOW and KLOW declared composition

The comparison below transcribes GLOW report MA-BLD-0009 and KLOW report MA-BLD-0010. It describes those named documents; the blend names alone do not define every similarly labelled material.GLOW 70 mg report: MA-BLD-0009 (opens in a new tab)KLOW 80 mg report: MA-BLD-0010 (opens in a new tab)

Labelled composition per vial in the supplied reports
ComponentGLOWKLOW
BPC-15710 mg10 mg
TB-50010 mg10 mg
GHK-Cu50 mg50 mg
KPVNot declared10 mg
Total70 mg80 mg
GLOW 70 mg report: MA-BLD-0009 (opens in a new tab)KLOW 80 mg report: MA-BLD-0010 (opens in a new tab)

The amount can stay the same while its fraction changes

Using those label declarations, GHK-Cu is 50/70, about 71.4%, of the GLOW component total and 50/80, or 62.5%, of the KLOW total. Its declared amount is 50 mg in both. These calculated fractions are based on component mass, not chromatographic peak area.GLOW 70 mg report: MA-BLD-0009 (opens in a new tab)KLOW 80 mg report: MA-BLD-0010 (opens in a new tab)

Both reports state that their peptide-related purity figure describes resolved peptide-related substances rather than the proportion of an individual blend component. Keep the mass-fraction calculation separate from that analytical result.GLOW 70 mg report: MA-BLD-0009 (opens in a new tab)KLOW 80 mg report: MA-BLD-0010 (opens in a new tab)

What a structural comparison still needs

Neither supplied report prints a complete sequence and terminal specification for every component. In particular, the TB-500 label should remain as written until its reference structure is documented. A blend has no single peptide sequence, molecular formula or molecular weight.GLOW 70 mg report: MA-BLD-0009 (opens in a new tab)KLOW 80 mg report: MA-BLD-0010 (opens in a new tab)

For a useful comparison, retain each component name and amount, the total, the lot and report revision, then add complete component structures when documented. The individual GLOW and KLOW references carry their own lot-specific result tables so those results need not be repeated here.GLOW 70 mg report: MA-BLD-0009 (opens in a new tab)KLOW 80 mg report: MA-BLD-0010 (opens in a new tab)

Products and certificate guides

Sources and further detail

  1. GLOW 70 mg report: MA-BLD-0009 (opens in a new tab)

    Supplied PDF re-read on 3 October 2026. Identity wording and document-specific results are transcribed; this is not independent authentication.

  2. KLOW 80 mg report: MA-BLD-0010 (opens in a new tab)

    Supplied PDF re-read on 3 October 2026. Identity wording and document-specific results are transcribed; this is not independent authentication.

Revised 3 October 2026 using the existing source dossier and the specified primary identity records. Report values describe the linked samples. Products are for laboratory research use only.

Novum Peptides

Research use only

Before you enter

Please confirm the following before browsing Novum Peptides.

Adults onlyYou must be 18 years or older to enter.

Laboratory research onlyOur products are not for human or veterinary use.

We’ll remember your confirmation on this browser where storage is available.

Novum Peptides · For laboratory research only